
Venigalla Srinivas
About Venigalla Srinivas
Data last updated:
Venigalla Srinivas is a Director at De Generic Bio-Tech Private Limited (since 2011). The companies operate in Life Sciences and Agriculture. De Generic Bio-Tech Private Limited reported revenue of ₹65.8 Lakh (FY 2014). Earlier, Venigalla Srinivas was a Director at Proprenz Biotech Private Limited (2018–2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 23 May 2011 | 2011 | ₹65.8 Lakh (FY 2014) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 27 Feb 2018 | 2018 | ₹4.55 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Venigalla Srinivas
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sai Kumar Akella | 03170783 | De Generic Bio-Tech Private Limited | Director |
| Vijay Kumar Pal | 07812849 | De Generic Bio-Tech Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Venigalla Srinivas
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Venigalla Srinivas
Venigalla Srinivas currently holds 1 directorship: De Generic Bio-Tech Private Limited (Director, since 23 May 2011, revenue ₹65.8 Lakh (FY 2014)).
Venigalla Srinivas was first appointed on 23 May 2011 as Director at De Generic Bio-Tech Private Limited. The most recent appointment on record is 27 Feb 2018 at Proprenz Biotech Private Limited.
Venigalla Srinivas held 1 earlier board appointment: Proprenz Biotech Private Limited (Director, 27 Feb 2018 to 27 Nov 2019).
The current boards of Venigalla Srinivas's companies include Sai Kumar Akella (De Generic Bio-Tech Private Limited), Vijay Kumar Pal (De Generic Bio-Tech Private Limited).